86301 Immunoassay tumor ca 19-9
Pathology & Lab
Also known as: CA 19-9, carbohydrate antigen 19-9
Carbohydrate antigen 19-9 (CA 19-9) immunoassay quantitatively measures tumor-associated antigen elevated in gastrointestinal cancers, particularly pancreatic and colon cancer.
Clinical Context
Elevated in pancreatic, gastric, and colorectal cancers. Used for monitoring treatment response and detecting recurrence. Not specific for cancer diagnosis.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.